U.S., Liberia kick off trial of Ebola drug ZMapp
February 27, 2015 at 12:50 PM EST
CHICAGO, Feb 27 (Reuters) - U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries.